These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1456880)

  • 21. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure.
    Selwood T; McCaslin DR; Schechter NM
    Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
    Dahlbäck B
    Thromb Haemost; 1991 Jul; 66(1):49-61. PubMed ID: 1833851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).
    Nakazawa F; Kannemeier C; Shibamiya A; Song Y; Tzima E; Schubert U; Koyama T; Niepmann M; Trusheim H; Engelmann B; Preissner KT
    Biochem J; 2005 Feb; 385(Pt 3):831-8. PubMed ID: 15654766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biochemistry of coagulation.
    Mann KG
    Clin Lab Med; 1984 Jun; 4(2):207-20. PubMed ID: 6238784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Procoagulant nature of fibrin].
    Béguin S
    Bull Acad Natl Med; 1998; 182(7):1479-91; discussion 1491-2. PubMed ID: 9916342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
    Diaz-Ricart M; Palomo M; Fuste B; Lopez-Vilchez I; Carbo C; Perez-Pujol S; White JG; Escolar G
    Thromb Res; 2008; 121(6):873-83. PubMed ID: 17904203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thapsigargin amplifies the platelet procoagulant response caused by thrombin.
    Smeets EF; Heemskerk JW; Comfurius P; Bevers EM; Zwaal RF
    Thromb Haemost; 1993 Dec; 70(6):1024-9. PubMed ID: 8165595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
    Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
    Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of signal peptidase by phospholipids in membrane: characterization of phospholipid bilayer incorporated Escherichia coli signal peptidase.
    Wang Y; Bruckner R; Stein RL
    Biochemistry; 2004 Jan; 43(1):265-70. PubMed ID: 14705954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of prothrombin by ASP, a serine protease released from Aeromonas sobria.
    Nitta H; Kobayashi H; Irie A; Baba H; Okamoto K; Imamura T
    FEBS Lett; 2007 Dec; 581(30):5935-9. PubMed ID: 18067862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cofactor role of vitamin K in blood coagulation processes].
    Khalmuradov AG; Shtutman TsM
    Vopr Pitan; 1980; (3):3-11. PubMed ID: 6996327
    [No Abstract]   [Full Text] [Related]  

  • 35. [Functional concept of the initiation of blood coagulation by cell membranes].
    Zubairov DM; Timerbaev VN
    Gematol Transfuziol; 1991 Apr; 36(4):5-9. PubMed ID: 2065967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of vitamin K antagonism.
    Bovill EG; Malhotra OP; Mann KG
    Baillieres Clin Haematol; 1990 Jul; 3(3):555-81. PubMed ID: 2271783
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation and regulatory role of gamma-carboxyglutamic acid containing clotting factors.
    Kalafatis M; Egan JO; van't Veer C; Mann KG
    Crit Rev Eukaryot Gene Expr; 1996; 6(1):87-101. PubMed ID: 8882309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin and the biochemistry of the vitamin K dependent proteins.
    Bovill EG; Mann KG
    Adv Exp Med Biol; 1987; 214():17-46. PubMed ID: 3310538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin formation.
    Mann KG
    Chest; 2003 Sep; 124(3 Suppl):4S-10S. PubMed ID: 12970118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential analytes for the diagnosis of thrombosis. An overview.
    Mann KG
    Ann Epidemiol; 1992 Jul; 2(4):365-70. PubMed ID: 1342287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.